甲状腺结节的射频消融(RATED研究)——学习曲线及成功预测因素分析
这项在荷兰3家转诊医院开展的回顾性观察性队列研究纳入337例患者356个结节,评估射频消融后12个月体积缩小率。每中心前20次治疗后体积缩小率趋于稳定,剩余299个结节12个月中位体积缩小率为70.8%;基线结节体积与12个月体积缩小率负相关,单位体积能量与体积缩小率无关。
要点
- 每中心前20次射频消融治疗后体积缩小率趋于稳定,之后进入平台期。
- 剩余299个结节3、6、12个月中位体积缩小率分别为57.1%、65.6%、70.8%。
- 基线结节体积与12个月体积缩小率负相关,但各体积类别体积缩小率均较高。
核心结论
- 甲状腺结节射频消融在每中心20次治疗后达到稳定疗效,中位体积缩小率为70.8%。
- 基线结节体积、释放能量及治疗后6个月以上的延长随访可能对预测治疗成功无临床相关性。
研究设计与样本
- 回顾性观察性队列研究,在荷兰3家转诊医院开展,纳入接受射频消融治疗症状性甲状腺结节且有超声随访的患者。
- 学习曲线分析共纳入337例患者356个结节;去除每中心前20次治疗后,剩余299个结节用于进一步分析。
主要发现
- 每中心前20次治疗中12个月体积缩小率逐次增加,此后稳定,提示学习曲线后进入平台期。
- 剩余299个结节3、6、12个月中位体积缩小率分别为57.1%、65.6%、70.8%。
- 基线结节体积与12个月体积缩小率负相关,但各体积类别体积缩小率均较高。
- 单位体积释放能量与体积缩小率无相关性。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Radiofrequency ablation (RFA) is used as treatment for symptomatic thyroid nodules. Factors influencing the volume reduction ratio (VRR) at 12 months are not yet fully understood. OBJECTIVE: The primary objective of this work was evaluating the VRR at 12 months after RFA. Secondary objectives were the assessment of a learning curve and factors influencing the VRR at 12 months. METHODS: A retrospective observational cohort study was conducted at 3 Dutch referral hospitals of patients who underwent RFA for symptomatic thyroid nodules with available ultrasound (US) follow-up. Main outcome measures included US-based VRR at 12 months and chronologically numbered RFA procedures. All patients' baseline, treatment, and early follow-up factors were assessed for correlation with VRR at 12 months. RESULTS: A total of 337 patients with 356 nodules were included in the learning curve analysis. VRR at 12 months increased for the first 20 treatments per center and stabilized thereafter, indicating a plateau phase after a learning curve. These initial cases were removed from further analysis. In the remaining 299 nodules, median VRR at 3, 6, and 12 months was 57.1%, 65.6%, and 70.8%. Baseline nodule volume negatively correlated with VRR at 12 months but VRR was high for every volume category. Energy delivered per volume did not correlate with VRR. CONCLUSION: In RFA for thyroid nodules, a stable treatment efficacy is achieved after 20 treatments, with a median VRR of 70.8%. Baseline nodule volume, energy delivered, and prolonged follow-up 6 months after treatment may not be clinically relevant to predict treatment success.
引用
- van der Meeren MMD, Boers T, de Graaf P, et al. Radiofrequency Ablation for Thyroid Nodules (RATED Study)-Analysis of a Learning Curve and Predictors of Success. J Clin Endocrinol Metab. 2025. PMID: 39880382. doi:10.1210/clinem/dgaf058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。